Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 124
- Markets & Stocks
Akanda’s Stock Price Jumps On Revenue Increase, MGC Pharma Secures EU-GMP At Malta Facility, & Cellular Goods Reports Growing Revenues
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda was one of a number of major European cannabis firms to release financial figures this week, days before announcing that it had secured a new ‘short-term’ $500k loan.
- Press releases
‘Protect Our Patients’ Campaign Launched
A new campaign calling for GPs to be allowed to prescribe medical cannabis to their patients has been launched by a group of leading industry organisations.
- Events
Cannabis Europa London 2023 – Day 2
AFTER a lively first day of sessions focused on the future of the cannabis industry, the second day of Cannabis Europa London 2023 opened with a look back at the industry’s very beginnings.
- Events
Cannabis Europa London 2023 – Day 1
The ninth edition of Europe’s leading cannabis conference, Cannabis Europa, returned to the Barbican Centre for the first time since its inception in 2018 this week, bringing together over a thousand of industry leaders, key policy makers from across the EU, and patient representatives.
- Cultivation
Hilltop Leaf ‘Officially Commences Trading In The UK’ Amid New Partnership With Little Green Pharma
SCOTLAND-based medical cannabis cultivation and extraction business Hilltop Leaf has announced a new supply deal with Australian medical cannabis firm Little Green Pharma (LGP), Business of Cannabis can reveal.
- Press releases
SafriCanna eyes explosive global growth following EU-GMP Certification milestone
SafriCanna, the largest producer of medicinal cannabis in Africa, has received confirmation of its EU-GMP Certification and outlined plans to drive fast growth through the global expansion of its sales.
- Press releases
MediproCan Pharma GmbH Partners With 314Pure Ltd to offer next level Canadian Cannabis to the German Market
The pharmaceutical company mediproCan Pharma GmbH has announced a new partnership with 314Pure Ltd., a licensed producer of high-quality cannabis in Canada.
- Uncategorized
MediproCan Pharma GmbH geht Partnerschaft mit 314Pure Ltd ein, um kanadisches Cannabis der nächsten Generation auf dem deutschen Markt anzubieten
Das Pharmaunternehmen mediproCan Pharma GmbH hat eine neue Partnerschaft mit 314Pure Ltd. bekannt gegeben, einem lizenzierten Hersteller von hochwertigem Cannabis in Kanada.
- CBD Market
Czech Republic Announces New Measures To Ban CBD, Portugal Tables Legalisation Bill, & Lithuania To Reconsider Decriminalisation
Czech Republic planning ban on CBD sales Despite being a driving force behind cannabis reform across Europe, food safety officials in the Czech Republic announced plans to ban the sale of CBD and other cannabinoids this week.
- CBD Market
Women in cannabis: Swiss KannaVations on closing the gender gap
Led by women and with a commitment to the research and development of products designed for women, Swiss KannaVations is disrupting the European cannabis space, with the aim of closing the gender health gap.
- Markets & Stocks
South West Brands Bought By Rival OTO For £6.2m, Deepverge Stock Falls 60%, & Yooma Wellness Expects Cease Trade Order
Deepverge [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”DVRG.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Deepverge, a biotech firm based in Dublin, has seen its stock freefall 60% since the start of the month after announcing that its prospective revenues would be ‘approximately 45-50%’ of previous estimates.
- Opinion
The UK ‘Should Ultimately Be Leading’ The World In Compassionate Clinical Cannabis Trials
Robin Emerson, CEO of the Jorja Emerson Centre, was introduced to the life changing impact medical cannabis can have after his daughter was diagnosed with a chromosome disorder which causes a severe form of epilepsy.










